Specialized Bio-specimen Supply New York Biologics Inc. specializes in providing human bio-specimens sourced from clinical laboratories and blood banks, presenting opportunities to collaborate with diagnostics companies seeking high-quality biological samples for research and development.

Growing Market Presence With revenue in the range of 1 to 10 million dollars, the company demonstrates a solid niche presence, offering potential for sales expansion through targeted outreach to emerging biotech and diagnostic firms looking for reliable specimen suppliers.

Industry Relationships Operating within the diagnostic and biomedical sectors since 1993, New York Biologics has built longstanding relationships, which can be leveraged to introduce complementary products or services such as laboratory automation, testing kits, or data management solutions.

Technical Infrastructure Their use of modern web technologies like MySQL and Google Analytics indicates an established digital footprint, offering channels for targeted marketing and digital engagement strategies to promote new product lines or partnerships.

Market Expansion Potential Given their focus on residual biological samples and support for the in-vitro diagnostic industry, there are growth opportunities by expanding into emerging clinical applications, personalized medicine, and research partnerships, increasing their market footprint.